Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Response to ASX aware letter dated 26 February 2025

13 March 20254 March 2025 by Karen Mobbs

Response to ASX aware letter dated 26 February 2025

Categories 2025, ASX Announcements
Prospectus
Commencement of rights trading on ASX
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 6 June 2025        Legal Notices and Privacy
Cleantalk Pixel